chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Extreme vertigo, nausea, headache 2 weeks after 2nd shot. Felt like I was going to faint every time I stood up. Never had vertigo before. Had to call in sick for work. Was able to get out of bed the next day but still not fully recovered after 5 days. Still feel dizzy and off balance. Waiting for it to fully go away. Never had any health problems before and never taken any prescribed medications. Took Dramamine, Tylenol and ear drops to see if it would help. Nothing helped.
It was noted on 2/23/22 that there was only a single dose of Hib left in the Pentacel box. We reviewed all patients that received this lot # and were able to narrow it down to this patient being the one that did not receive Hib. A safety report has been filed with the manufacturer. The Owner/Physician of our practice has been notified and will be reaching out to the family to schedule the dose of hib. Sanofi is shipping a pack of hib diluent so we can administer the remaining vaccine.
Sharp pain in my upper arm, wrapping around to my triceps, into my left trapezius and up into the left side of my neck. At about that same time, I developed pain in my left wrist and in the pinky and ring fingers of my left hand. Pain has continued for more than two months now despite regular stretching of the affected areas, use of a wrist brace, and applications of Icy Hot patches to my arm and upper back.
Information has been received from a 26 year old male patient referring to himself. The patient's pertinent medical history, concurrent conditions and concomitant medications were not reported. No previous drug reactions or allergies were reported. On an unknown date the patient was vaccinated with (wistar ra 27-3) M-M-R II, 1 DF (1 injection), (lot # N023154, expiry date: 24-AUG-2019) intramuscularly for prophylaxis, GARDASIL 9 and ENGERIX-B one hour apart (inappropriate schedule of drug administration). Per the prescribing information for measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), it is indicated that (wistar ra 27-3) M-M-R II should be given one month before or after administration of other live viral vaccines. It was not indicated in the prescribing information that GARDASIL 9 is a live vaccine. It is uncertain if ENGERIX-B is or is not a live viral vaccine. Patient confirmed that he did not experience any adverse effects after taking the vaccines. No product quality complaint reported.
Myalgia, arthralgia, fever, cough wheeze, urticarial pruritus and shortness of breath. Diphenhydramine, ibuprofen.
Chills fever rash on arm right below injection site, also itching on my back.  The red rash on my arm is still there today 1/24/2021.
Vomit 30 minutes after administration.  approx. 9 hours later, resident has Stroke-like symptoms.  He was previously on Hospice before admitting to our facility and planned to be readmitted to hospice upon discharge.
Very severe back pain. Had swelling at vaccine site the day after shot. Back pain started two days after shot.
Severe pain in both knees, getting up and down from chair increased the pain. Left knee pain subsided in about 5-6 days. Right knee got worse. At my PCP on 10/14/2021 and she looked at knee. Got a x-ray on 10/15. Showed advanced arthritis and referred to an orthopeadic surgeon to consider a knee replacement.
gen body aches, mildly dec breath sounds, mild epigastric pain, nausea, vomiting;
Patient received Janssen vaccine. Patient did not disclose during screening and completion of consent form that Moderna COVID-19 vaccine had previously been received. During immunization record entry in ALERT,  Immunization database, it was revealed that patient had previously received 2 doses of Moderna. - 04/21/2021 Moderna Lot: 047B21A - 06/04/2021 Moderna Lot: 034C21A  Provider on Duty (POD) r contacted patient 24 hours post vaccination for follow-up. Patient reported feeling well with no side affects. Patient disclosed rationale for receiving 3rd COVID-19 vaccination as fear of the Delta variant of the COVID-19 virus, lifting of the  mandate on mask wearing, and wanting maximum protection against COVID-19 infection.
Within less than a month of the vaccines I developed ringing in the ears that continues to this day.  It is very disturbing.
A BOOSTRIX (Tdap) vaccine was given inadvertently given to a 24 y.o. female although the vaccine is not recommended for this age. The CDC was contacted and advised that a second injection did not need to be given, the Pt should be considered immunized. The vaccine was administered at the local health department.
22 hours after the vaccination I received almost all of the side effects. They were extreme for 48 hours. They included (fever, head-ache, vomiting, chills, muscle pain, joint pain, swelling and extreme pain in my lymph nodes.  Let me note that I am 69 years old with no health conditions. I am not on any medication and in perfect health.
Patient passed away unrelated to covid vaccine Narrative: The patient received his first dose of Moderna on 1/14 and he was rushed to the hospital at 4 am on 1/15. The patient tested positive for COVID and is hospitalized in the hospital. The patient passed away on 2/8. Cause of death not documented, possibly due to COVID complication. No indication that death was related to COVID 19 vaccination.
Public Health Nurse administered Hepatitis B vaccine in error. Client had completed the 3 dose series.
2 patients administered dose out of a vial that was in the fridge for 31 days; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (2 patients administered dose out of a vial that was in the fridge for 31 days) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (2 patients administered dose out of a vial that was in the fridge for 31 days). On 10-Sep-2021, EXPIRED PRODUCT ADMINISTERED (2 patients administered dose out of a vial that was in the fridge for 31 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No  concomitant information provided by the reporter No treatment information provided by the reporter  It was reported that Pharmacist did not know if it was consumer's 1st or second dose .2 doses administered out of a vial that was in the adverse events fridge for 31 days.
pain in the eyes; the eye lids are swollen; This spontaneous case was reported by a consumer and describes the occurrence of EYE PAIN (pain in the eyes) and EYE SWELLING (the eye lids are swollen) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced EYE PAIN (pain in the eyes) and EYE SWELLING (the eye lids are swollen). At the time of the report, EYE PAIN (pain in the eyes) and EYE SWELLING (the eye lids are swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included Compress of cold water. Patient reports vision is fine, not cloudy and is able to focus.
The patient has not experienced any adverse events but was given a dose of vaccine that was not mixed correctly. It was too concentrated.
pt recv vax & devel a h/a & T103 which lasted for 3 days & breakthrough varicella w/80-100 itchy lesions;on approx 4/30/98 pt recovered;
Site: Itching at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Systemic: Fever-Mild, Additional Details: patient said her fever resolved after 24 hours. area of injection is warm to touch, slight swelling and has redness
Rashes, itching, swelling after two hours of giving vaccine, she was given Benadryl 50mg IVP. paramedics were called. Employee went home against medical advice
Pain in entire arm, redness, swelling, tenderness, tingling in fingers, stiffness, infection of injection site.
Vomiting diarrhea next day of administration associated with facial swelling as well as (L) breast swelling.
I was treated for a urinary infection with the antibiotic Keflex.  Within hours of taking the first dose I had an extremely bad reaction to the antibiotic. I can't describe the feeling because it was unlike any I have ever had. But I felt the worst I have ever felt in my life. The reaction was intense for 36 hours. It was so bad I could not even sit up.  The reaction was not so dramatic after 36 hours but I was still feeling miserable until I quit taking the drug. Then I felt fine.
Approx 10 days after first vaccine developed red, mildly indurated, warm, itchy area approx 3 x 6 inches which took 8 days to resolve
Pt came to clinic for second covid vaccine.  Completed paperwork/screening questions.  Did not advise that had had previous injection at another site.  Nurse administered Moderna vaccine.  When she provided card, pt handed her a card that indicated that she had had a dose of pfizer on   4/21/21.  CDC recommendations reviewed.  Pt advised of error and CDC recommendation. Understanding verbalized.  No issue during observation period.
Patient received 0.3ml of Comirnaty 23-24 on 10/30/23 . Later in evening developed rash on chest and neck.  Was evaluated by her MD and breathing ok.  Given benadryl.
Narrative:  98yo male with PMH; LEGALLY BLIND HAS CAREGIVER COLON CA RESECTION THEN CHEMO 1999--PT REPORTS NO METS OR RECURRENCE;F/U ONCOLOGY OUTSIDE HTN; GERD-MINISTROKE ON AGGRENOX PLAVIX FAILURE STROKE'; GLAUCOMA; S/P PACEMAKER B12 DEFICIENCY ANEMIA /REFUSED SHOTS TAKES TABS RENAL CYSTS / ON CT PT REFUSED ANY MORE CT SCAN F/U AT THIS AGE C SCOPE NL 2007 , GI HAS STOPPED COLONOSCOPY DUE TO AGE PT HAS REFUSED ANY MORE COLONOSCOPIES has died on 12/15/2021 at HOSPITAL . No info about pt's death provided. Pt had received covid vaccines on 1/8/21 & 2/5/21 & 11/22/21. Likely this death is not related to the covid vaccines given pt's advanced age and comorbidities.
Shrill cry x 2 1/2 hrs projectile vomit x 2; lt leg red, swollen; unable to move lt leg next AM & few hrs p/that restless during noc; MD talked w/mom wanted clinic notified;
nauseous; tired; feeling unwell/ Felt badly; sore arm; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 19th April 2019, the patient received the 1st dose of Shingrix. On 19th April 2019, less than a day after receiving Shingrix, the patient experienced pain in arm and feeling unwell. On 20th April 2019, the patient experienced nausea and tiredness. On 21st April 2019, the outcome of the nausea, tiredness and feeling unwell were recovered/resolved. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm, nausea, tiredness and feeling unwell to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix on an unknown arm. The patient felt badly after receiving Shingrix. The patient's arm became sore on the day of receiving Shingrix and the next one day after vaccination she experienced nauseous and tiredness. This case was linked with case US2019116892 reported by the same reporter. There is a discrepancy between the outcome reported in the structured field "resolved with sequelae" and the outcome reported in the sender's comment "recovered/resolved" for all events.
Red, raised rash that resembled mosquito bites on and around four injection sites which include right and left upper arm and right and left thighs.
Immediately after vaccine injection, staff and supervisor reports: hives on arms, face and chest. Itchiness on body and throat. BENADRYL PO given with improvement 30 min - 1 hour after medication.
Acute local reaction to injection with erythema and swelling and induration in 4 x 4 area around injection site treatment Benadryl and hydrocortisone cream.
I have been experiencing leg cramps especially in my knees.  Walking affected.  Not always in pain when sitting. These symptoms started probably sometime after receiving the second shot of Pfizer.  It took me awhile to associate the timing of these symptoms with the possibility they could be related to the vaccine.  I am reporting this so you will have a record and possibly have other similar reports.
Headache, Myalgia, Arthralgia, fatigue Narrative:  flu like symptoms causing employee to finish work early  Other Relevant History:
Child was seen to become stiff and slump to the side. Had 2-3 minutes of amnesia. Laid flat Measure BP low. Woke spontaneously with bad headache. Headache has now improved after 6 days to moderate, but persists. Child reuses acetaminophen of ibuprofen. Mom says she has trouble concentrating.
Information has been received from an office worker concerning a female (age not reported) who was vaccinated on unspecified dates with her first and second dose of Gardasil (lot number unknown) 0.5 mL injection. The office worker reported that on an unspecified date the patient developed a large, hot welt, size of a baseball on her right deltoid 24 hours after receiving her third dose of Gardasil (lot number unknown) 0.5 mL injection. Medical attention was sought. On 24-APR-2007 the patient recovered from the adverse which lasted about four days. No additional information was provided. Additional information has been requested.
Sore arm for a couple of days (left); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm for a couple of days (left)) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 010M20A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included MESALAZINE (MESALAMINE) for Ulcerative colitis.   On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (Sore arm for a couple of days (left)). On 02-Mar-2021, VACCINATION SITE PAIN (Sore arm for a couple of days (left)) outcome was unknown.            No treatment medication was provided.   The patient had no side effects after taking first dose.
Ten days after I received the 2nd Moderna vaccination, I had a TIA stroke (double vision, right side of face and right became numb, slurred speech, could not walk).  I received a TPA shot within an hour an 15 minutes of the stroke.  I have no long term side effects from the stroke.  I will take blood thinners the rest of my life.
None- vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 011L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment information was not provided.   This case was linked to MOD-2021-395985 (Patient Link).
Tinnitus was intermittent after first dose.  Then consistent after second dose; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 63-year-old non-pregnant female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: el9265), via an unspecified route of administration, administered in left arm on 12Feb2021 at 08:00 (at the age of 63-years-old) as dose 1, single for COVID-19 immunisation. The medical history of the patient included high blood pressure, ankolosing spondylitis. The concomitant medications included hydrochlorothiazide (HYDROCHLOROTHIAZIDE), metoprolol (METOPROLOL) and Silva sala one 50 mg. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the covid vaccine. Prior to vaccination, the patient was not diagnosed with covid-19. Since the vaccination, the patient not been tested with covid-19. On 21Feb2021 at 09:00, the patient experienced tinnitus was intermittent after first dose. then consistent after second dose. No therapeutic measures were taken as a result of event. The outcome of the event was reported as not resolved.   Follow-up attempts are completed. No further information is expected.
Pt was given a Pfizer booster and she is only 16 years old and NOT immunocompromised.  Pt's mom scheduled the appt for pt and wanted her to get the booster and was not aware that she was too young. Pt felt fine at the time of discharge. Mom and patient were both notified as soon as I realized that I had made an error by giving the patient the booster.
1. nerve pain/tingling in feet after getting out of bed or after moving from sitting to standing/walking/no treatment/ongoing 2. lack of menses since initial shot/no treatment/ongoing
Narrative: Death not suspected to be due to vaccine administration. Per death certificate, patient passed due to comorbid conditions including COPD, CAD, and T2DM.
presented to the emergency room with complaints of recurrent slurred speech waxing and waning for the past 5 days. Patient reports that he tested positive for COVID-19 virus infection about 10 days ago and thought that his speech symptoms maybe related to that. He denies any fever, chills, shortness of breath, cough or sputum production. He reports off-and-on numb sensation all over his body and denies any focal weakness, facial droop, or headache or visual disturbance. CT of the head was done in the emergency room showing no acute intracranial abnormality. His symptoms slowly and gradually resolved. Chest x-ray was done showing multifocal patchy interstitial infiltrates consistent with pneumonitis. Not changed from previous exam. Labs showed CBC and CMP at baseline with a negative troponin test and positive COVID-19 test.
Headache; Low grade fever - 99.3; Shaky and jittery feeling that kept me from sleeping soundly; Shaky and jittery feeling that kept me from sleeping soundly; Shaky and jittery feeling that kept me from sleeping soundly; This is a spontaneous report from a contactable Healthcare Professional reporting for a patient. A 44-years-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE); Lot Number: EK5730), intramuscular in the left arm on 30Dec2020 at 09:00  as a single dose,  for COVID-19 immunisation. The patient had no known medical history or allergies. Concomitant medication included rosuvastatin calcium (CRESTOR).  No other vaccines were given within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. On 30Dec2020 at 2300,  the patient experienced Headache, Low grade fever - 99.3, Shaky and jittery feeling that kept me from sleeping soundly. No treatment was given for the events. The clinical outcome of Headache, Low grade fever - 99.3, Shaky and jittery feeling that kept me from sleeping soundly was recovering.
PATIENT WAS MONITORED FOR 15 MINUTES AFTER RECEIVING INJECTION.  AFTER LEAVING, RETURNED TO VACCINE POD COMPLAINING OF SWELLING OF TONGUE AND THROAT AND SHORTNESS OF BREATH.  EMS EVALUATED PATIENT AND SHE WAS TAKEN TO HOSPITAL WHERE SHE WAS TREATED FOR ANAPHYLAXIS AND RELEASED.
Extreme dizziness; severe abdominal cramps, diarrhea, weakness, 103 degree fever. Following day dizziness, weakness cont'd.
jaw pain; gum infection; pain; tiredness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN JAW (jaw pain), GINGIVITIS (gum infection), PAIN (pain) and FATIGUE (tiredness) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-May-2021, the patient experienced PAIN IN JAW (jaw pain), GINGIVITIS (gum infection), PAIN (pain) and FATIGUE (tiredness). At the time of the report, PAIN IN JAW (jaw pain), GINGIVITIS (gum infection), PAIN (pain) and FATIGUE (tiredness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment reported: Advil   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Non significant Follow up appended
Fever 100, very sore arm, headache, nausea. Rt deltoid.
Patient reports feeling poorly starting the night of vaccine. She reports nausea, dizziness, diarrhea, vertigo and had an episode of syncope leading patient to seek treatment at the emergency department
Liquid stool and sense of urgency (I didn't make it to the bathroom X2)  Over a period of approx. 2 hrs. Self resolved
Shortly after vaccination, client experienced itchy throat with slight difficulty swallowing, no difficulty breathing. After coming to ambulance, ambulating independently, some redness on chest was noted. Client given 0.3 mg epinephrine IM, 50 mg Benadryl IVP, and 100mL normal saline. Then they were transported to ER.
This spontaneous report as received from a health professional, refers to unspecified number of patients of unknown demography. No concurrent condition, medical history or allergy/drug reactions were reported. On an unspecified date, unspecified number of patients were vaccinated with improperly stored ROTATEQ (strength, dose, route and lot number or batch number unspecified). No concomitant medications were reported. No adverse effects were reported. The outcome of the event was unknown. There were no product quality complaints (PQC) involved. No further information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report was received from a registered nurse refers to unspecified patients of unknown age and gender. Concurrent conditions, medical history and concomitant medications were not reported. The reporter stated that, the patients were vaccinated with improperly stored doses (temperature excursion: 48.7 F, time frame: 3 hours) of M-M-R II with lot # L013429, expiry date 21-JUL-2017 (dose, dose number, vaccination site and route of administration not provided) since 02-FEB-2016. There was no previous temperature excursion. No adverse effects were reported. Product quality complaint (PQC) was not involved. This is one of two reports from the same reporter. Additional information has been requested.
Vaccine was expired for 15 days. Given inadvertently due to confusion in extended dates. vaccine stored in refrigerator and not ultra-cold. Used ultra-cold extended date instead of 10 week expiration date.